A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions.

The pharmaceutical industry has kicked off third-quarter earnings, and we're here to give you a preview of the biggest names set to report this week.

It's been a tumultuous year for drugmakers. They have had to navigate the Trump administration's rapidly changing drug pricing policies, threats of pharmaceutical tariffs, pressure to ramp up U.S. manufacturing and Health and Human Services Secretary Robert F. Kennedy Jr.'s massive overhaul of federal health agencies, among other issues.

Top of mind for investors is any details on potential "most favored nation" drug pricing deals with President Dona

See Full Page